Hostname: page-component-669899f699-rg895 Total loading time: 0 Render date: 2025-04-25T07:39:58.215Z Has data issue: false hasContentIssue false
  • English
  • Français

The (Frequently) Neuroleptic (Potentially) Malignant Syndrome

Published online by Cambridge University Press:  02 January 2018

A. M. P. Kellam
A. M. P. Kellam*
Affiliation:
Whitchurch Hospital and The University Hospital of Wales, Heath Park, Cardiff CF4 4XW, Wales
Get access Rights & Permissions [Opens in a new window]

Extract

Since a previous review (Kellam, 1987), the subject of neuroleptic malignant syndrome (NMS) has continued to cause considerable interest, particularly in the USA where there is still controversy about its frequency, despite two attempts to survey prospectively all cases admitted to two different hospitals. Cases of NMS are now being more widely recognised by non-psychiatrists, especially geriatricians.

Type
Annotation
Information
The British Journal of Psychiatry , Volume 157 , Issue 2 , August 1990 , pp. 169 - 173
Copyright
Copyright © Royal College of Psychiatrists, 1990 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Adityanjee, , (1987) Role of electroconvulsive therapy in neuroleptic malignant syndrome. Acta Psychiatrica Scandinavica, 76, 603–604.Google Scholar
Adityanjee, , Singh, S., Singh, G., et al (1988) Spectrum concept of neuroleptic malignant syndrome. British Journal of Psychiatry, 153, 107–111.Google Scholar
Addonozio, G. (1987) Neuroleptic malignant syndrome in elderly patients. Journal of the American Geriatric Society, 35, 1011–1012.CrossRefGoogle Scholar
Addonozio, G., Susman, V. L. & Roth, S. D. (1986) Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry, 143, 1587–1590.Google Scholar
Barnes, M. P., Saunders, M., Walls, T. J., et al (1986) The syndrome of Karl Ludwig Kahlbaum. Journal of Neurology, Neurosurgery and Psychiatry, 49, 991–996.CrossRefGoogle ScholarPubMed
Castillo, E., Rubin, R. T. & Holsboer-Trachsler, E. (1989) Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 324–328.Google Scholar
Coquet-Le Pape, B. (1989) Catatonie aigue et syndrome malin des neuroleptiques. These pour le Diplome d'Etat de Docteur en Medicine. Unpublished thesis, University of Rennes.Google Scholar
Finucane, P., Price, C. & Ghose, K. (1988) Neuroleptic malignant syndrome in an elderly patient. British Medical Journal, 296, 18.Google Scholar
Fogel, B. S. & Goldberg, R. J. (1985) Neuroleptic malignant syndrome (letter). New England Journal of Medicine, 313, 1292.Google Scholar
Gelenberg, A. J., Bellinghausen, B., Wojcik, J. D., et al (1988) A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital. American Journal of Psychiatry, 145, 517–518.Google Scholar
Goldwasser, H. D., Hooper, J. F. & Spears, N. M. (1989) Concomitant treatment of neuroleptic malignant syndrome and psychosis. British Journal of Psychiatry, 154, 102–104.Google Scholar
Hamburg, P., Weilburg, J. B., Cassem, N. H., et al (1986) Relapse of neuroleptic malignant syndrome with early discontinuation of amantadine therapy. Comprehensive Psychiatry, 27, 272–275.Google Scholar
Hermesh, H., Aizenberg, D. & Weizman, A. (1987) A successful electroconvulsive treatment of neuroleptic malignant syndrome. Acta Psychiatrica Scandinavica, 75, 237–239.CrossRefGoogle ScholarPubMed
Hermesh, H., Aizenberg, D., Lapidot, M., et al (1988) Risk of malignant hyperthermia among patients with neuroleptic malignant syndrome and their families. American Journal of Psychiatry, 145, 1431–1434.Google ScholarPubMed
Keck, P. E., Pope, H. G. & McElroy, S. L. (1987) Frequency and presentation of neuroleptic malignant syndrome: a prospective study. American Journal of Psychiatry, 144, 1344–1346.Google Scholar
Kellam, A. M. P. (1987) The neuroleptic malignant syndrome, so-called. British Journal of Psychiatry, 150, 752–759.CrossRefGoogle Scholar
Knezevic, W., Mastaglia, F. L., Lefroy, , et al (1984) Neuroleptic malignant syndrome. Medical Journal of Australia, 140, 28–30.Google Scholar
Kosten, T. R. & Kleber, H. D. (1988) Rapid death during cocaine abuse; a variant of the neuroleptic malignant syndrome? American Journal of Drug and Alcohol Abuse, 14, 335–346.Google Scholar
Lazarus, A. (1986a) Treatment of neuroleptic malignant syndrome with electroconvulsive therapy. Journal of Nervous and Mental Disorders, 174, 47–49.CrossRefGoogle ScholarPubMed
Lazarus, A. (1966b) Therapy of neuroleptic malignant syndrome. Psychiatric Developments, 1, 19–30.Google Scholar
Levinson, D. F. & Simpson, G. M. (1986) Neuroleptic-induced extrapyramidal symptoms with fever. Archives of General Psychiatry, 43, 839–847.Google Scholar
Mann, S. C., Caroff, S. N., Bleier, H. R., et al (1986) Lethal catatonia. American Journal of Psychiatry, 143, 1374–1381.Google Scholar
Padgett, R. & Lipman, E. (1989) Use of neuroleptics after an episode of neuroleptic malignant syndrome. Canadian Journal of Psychiatry, 34, 323–325.CrossRefGoogle ScholarPubMed
Pope, H. G., Keck, P. E. & McElroy, S. L. (1986) Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry, 143, 1227–1233.Google Scholar
Rosebush, P. & Stewart, T. (1989) A prospective analysis of 24 episodes of neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 717–725.Google Scholar
Rosebush, P., Stewart, T. & Gelenberg, A. J. (1989) Twenty neuroleptic re-challenges after neuroleptic malignant syndrome in 15 patients. Journal of Clinical Psychiatry, 50, 295–298.Google Scholar
Rosenberg, M. R. & Green, M. (1989) Neuroleptic malignant syndrome. Archives of Internal Medicine, 149, 1927–1931.Google Scholar
Serby, M. (1986) Neuroleptic malignant syndrome in Alzheimer's disease. Journal of the American Geriatric Society, 34, 895–896.Google Scholar
Shalev, A., Hermesh, H. & Munitz, H. (1988) The role of external heat load in triggering the neuroleptic malignant syndrome. American Journal of Psychiatry, 145, 110–111.Google Scholar
Shalev, A., Hermesh, H. & Munitz, H. (1989) Mortality from neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 50, 18–25.Google Scholar
Slack, T. & Stoudemire, A. (1989) Reinstitution of neuroleptic treatment with molindone in a patient with a history of neuroleptic malignant syndrome. General Hospital Psychiatry, 11, 365–367.Google Scholar
Susman, V. L. & Addonozio, G. (1987) Reinduction of neuroleptic malignant syndrome by lithium. Journal of Clinical Psychopharmacology, 7, 339–341.Google Scholar
Tesar, G. E. (1988) Neuroleptic malignant syndrome an update. Problems in Critical Care, 2, 149–158.Google Scholar
Wells, A. J., Sommi, R. W. & Crismon, M. L. (1988) Neuroleptic rechallenge after neuroleptic malignant syndrome; case report and literature review. Drug Intelligence and Clinical Pharmacy, 22, 475–480.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.